eHealth earnings release, August 4, 2026

eHealth, Inc. (EHTH) · Form 8-K, Item 2.02 · Filed · SEC filing

eHealth, Inc. Announces Second Quarter 2026 Results

Lifetime Advisory Model increasing member engagement

On track to achieve meaningful YoY improvements in annual operating cash flow

INDIANAPOLIS — August 4, 2026 — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June 30, 2026.

■

Total revenue declined 45% year-over-year reflecting lower Medicare enrollment volume, consistent with our strategy to reduce variable marketing spend outside of major enrollment periods and focus benefit advisors on existing member engagement.

■

Q2 2026 positive net adjustment revenue of $7.6 million compared to $17.8 million in prior year.

■

Launched lifetime advisory model with a goal of deepening member-advisory relationships and driving increased engagement, retention and member lifetime values.

■

Q2 2026 ancillary product cross-sell rates doubled compared to prior year and observed improvements in additional member engagement metrics, reflecting early success of new operating model.

■

Total operating costs and expenses decreased

27% to $61.0 million compared to $83.8 million in prior year driven by cost reduction program implemented in January.

■

On track to achieve more than $60.0 million in annual variable spend reductions and approximately $30.0 million in annual fixed cost savings compared to prior year.

■

Operating cash flow improved by $36.2 million year-over-year, reflecting disciplined expense management and targeted cost reduction initiatives.

■

Commissions receivable balance as of June 30, 2026 represents 10% growth from June 30, 2025.

■

Advanced efforts towards building ICHRA business, including developing our pipeline, expanding strategic partnerships, strengthening broker relationships and continuing to refine our operating model.

__________

Note: See the tables at the end of this press release for a reconciliation of our GAAP financial measures to our non-GAAP financial measures for the relevant periods and footnote (1) on page¹⁴ at the end of this press release for definitions of our non-GAAP financial measures. Additionally, see accompanying footnotes on page¹⁴ for additional definitions.¹

Financial statements

Income Statement

Q2 2026 Key Financial Results

Q2 2026 Key Financial Results – Adjusted EBITDA(1)
$33.6M$(21.8)M
vs $60.8Mvs $(14.1)M
Comparisons above reflect the comparable metrics from the three months ended June 30, 2025.Cash, Cash Equivalents & Short-Term Marketable SecuritiesCommissions Receivable
Comparisons above reflect the comparable metrics from the three months ended June 30, 2025.$101.0M$1.0B

Income Statement

Three Months Ended June 30, — (in thousands, except per share amounts, unaudited)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Three Months Ended June 30, – 2025% ChangeSix Months Ended June 30, – 2026Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025Six Months Ended June 30, – 2025% Change
Revenue:Commission29,80454,731-46.0%109,611153,677-29.0%
Revenue:Other3,7626,051-38.0%11,97320,224-41.0%
Revenue:Total revenue33,56660,782-45.0%121,584173,901-30.0%
Operating costs and expenses(a):Marketing and advertising11,78121,425-45.0%37,17462,614-41.0%
Operating costs and expenses(a):Customer care and enrollment22,29827,910-20.0%54,58265,131-16.0%
Operating costs and expenses(a):Technology and content11,30111,35422,63623,955-6.0%
Operating costs and expenses(a):General and administrative15,58321,582-28.0%31,09538,892-20.0%
Operating costs and expenses(a):Impairment, restructuring and other charges601,555-96.0%6,4321,555314.0%
Operating costs and expenses(a):Total operating costs and expenses61,02383,826-27.0%151,919192,147-21.0%
Operating costs and expenses(a):Loss from operations-27,457-23,044-19.0%-30,335-18,246-66.0%
Operating costs and expenses(a):Interest expense-4,054-2,348-73.0%-8,089-4,996-62.0%
Operating costs and expenses(a):Other income, net8321,340-38.0%1,6722,916-43.0%
Operating costs and expenses(a):Loss before income taxes-30,679-24,052-28.0%-36,752-20,326-81.0%
Operating costs and expenses(a):Benefit from income taxes-7,084-6,654-8,443-4,878
Operating costs and expenses(a):Net loss-23,595-17,398-36.0%-28,309-15,448-83.0%
Operating costs and expenses(a):Preferred stock dividends-6,201-5,846-12,334-11,627
Operating costs and expenses(a):Change in preferred stock redemption value-7,715-6,539-14,975-12,680
Operating costs and expenses(a):Net loss attributable to common stockholders-37,511-29,783-26.0%-55,618-39,755-40.0%
Net loss per share attributable to common stockholders:Basic and diluted-1.18-0.98-18.0%-1.77-1.32-34.0%
Weighted-average number of shares used in per share:Basic and diluted31,78030,4045.0%31,45830,2024.0%
_____________________________ (a) Includes stock-based compensation expense as follows:Marketing and advertising3805856481,082
_____________________________ (a) Includes stock-based compensation expense as follows:Customer care and enrollment224332448596
_____________________________ (a) Includes stock-based compensation expense as follows:Technology and content3716806991,368
_____________________________ (a) Includes stock-based compensation expense as follows:General and administrative1,3552,2792,7934,619
_____________________________ (a) Includes stock-based compensation expense as follows:Total stock-based compensation expense2,3303,876-40.0%4,5887,665-40.0%
Non-GAAP Results(1):Adjusted EBITDA(1)-21,776-14,142-54.0%-12,766-1,621-688.0%
Non-GAAP Results(1):Adjusted EBITDA margin(1)-65%-23%-10%-1%

Income Statement

Three Months Ended June 30, — The results of our reportable segments are summarized for the periods presented below:

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025% ChangeSix Months Ended June 30, – 2026Six Months Ended June 30, – 2025% Change
Medicare:Total revenue31,79958,059-45.0%113,070161,728-30.0%
Medicare:Variable marketing and advertising-5,793-13,80058.0%-24,522-47,55348.0%
Medicare:Medicare CC&E-19,832-25,07821.0%-49,444-59,54717.0%
Medicare:Cost of revenue-210-36-104264-139.0%
Medicare:Medicare segment gross profit5,96419,145-69.0%39,00054,892-29.0%

Income Statement

Three Months Ended June 30, — The results of our reportable segments are summarized for the periods presented below:

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025% ChangeSix Months Ended June 30, – 2026Six Months Ended June 30, – 2025% Change
Employer and Individual:Total revenue1,7672,723-35.0%8,51412,173-30.0%
Employer and Individual:Variable marketing and advertising-613-71715.0%-1,456-1,90724.0%
Employer and Individual:E&I CC&E-1,939-2,20112.0%-4,081-4,3817.0%
Employer and Individual:Cost of revenue-55-6211.0%-121-15421.0%
Employer and Individual:E&I segment gross profit (loss)-840-257-227.0%2,8565,731-50.0%

Income Statement

Three Months Ended June 30, — A reconciliation of our total segment gross profit to the Condensed Consolidated Statements of Operations for the periods presented is as follows:

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025% ChangeSix Months Ended June 30, – 2026Six Months Ended June 30, – 2025% Change
Total segment gross profit5,12418,888-73.0%41,85660,623-31.0%
Other marketing and advertising(a)-5,110-6,81025.0%-10,971-13,26417.0%
Other CC&E(b)-527-63116.0%-1,057-1,20312.0%
Technology and content-11,301-11,354-22,636-23,9556.0%
General and administrative-15,583-21,58228.0%-31,095-38,89220.0%
Impairment, restructuring and other charges-60-1,55596.0%-6,432-1,555-314.0%
Interest expense-4,054-2,348-73.0%-8,089-4,996-62.0%
Other income, net8321,340-38.0%1,6722,916-43.0%
Loss before income taxes-30,679-24,052-28.0%-36,752-20,326-81.0%

Income Statement

Three Months Ended June 30, — :

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025Six Months Ended June 30, – 2025
GAAP net loss attributable to common stockholders-37,511-29,783-55,618-39,755
Preferred stock dividends6,2015,84612,33411,627
Change in preferred stock redemption value7,7156,53914,97512,680
GAAP net loss-23,595-17,398-28,309-15,448
Stock-based compensation expense2,3303,8764,5887,665
Depreciation and amortization3,2913,4716,5497,405
Impairment, restructuring and other charges601,5556,4321,555
Interest expense4,0542,3488,0894,996
Other income, net-832-1,340-1,672-2,916
Benefit from income taxes-7,084-6,654-8,443-4,878
Adjusted EBITDA(1)-21,776-14,142-12,766-1,621
Net loss margin-70%-29%-23%-9%
Adjusted EBITDA margin(1)-65%-23%-10%-1%

Income Statement

(in millions):

Full Year 2026 Guidance – Low – $Full Year 2026 Guidance – High – $
Impact from preferred stock5757
GAAP net income825
Stock-based compensation expense1312
Depreciation and amortization1312
Impairment, restructuring and other charges66
Interest expense1413
Other income, net-3-3
Provision for income taxes410

Balance Sheet

June 30, 2026 — (in thousands, unaudited)

June 30, 2026December 31, 2025
Current assets:Cash and cash equivalents69,68173,725
Current assets:Short-term marketable securities31,3673,495
Current assets:Accounts receivable1,8187,688
Current assets:Contract assets – commissions receivable – current202,804236,116
Current assets:Prepaid expenses and other current assets10,08313,328
Current assets:Total current assets315,753334,352
Current assets:Contract assets – commissions receivable – non-current804,806886,614
Current assets:Property and equipment, net4,1054,531
Current assets:Operating lease right-of-use assets6,9158,429
Current assets:Restricted cash2,6303,090
Current assets:Other assets23,82325,452
Current assets:Total assets1,158,0321,262,468
Current liabilities:Accounts payable2,95328,323
Current liabilities:Accrued compensation and benefits14,87841,009
Current liabilities:Accrued marketing expenses2,77916,182
Current liabilities:Lease liabilities – current6,6157,349
Current liabilities:Other current liabilities4,5246,207
Current liabilities:Total current liabilities31,74999,070
Current liabilities:Long-term debt114,608112,954
Current liabilities:Deferred income taxes – non-current48,56657,223
Current liabilities:Lease liabilities – non-current10,95014,050
Current liabilities:Other non-current liabilities5,0735,519
Current liabilities:Total liabilities210,946288,816
Current liabilities:Convertible preferred stock406,283382,057
Stockholders’ equity:Common stock4644
Stockholders’ equity:Additional paid-in capital752,110761,495
Stockholders’ equity:Treasury stock, at cost-199,998-199,998
Stockholders’ equity:Retained earnings (deficit)-11,58630,116
Stockholders’ equity:Accumulated other comprehensive income (loss)231-62
Stockholders’ equity:Total stockholders’ equity540,803591,595
Stockholders’ equity:Total liabilities, convertible preferred stock and stockholders’ equity1,158,0321,262,468

Cash Flow

Three Months Ended June 30, — (in thousands, unaudited)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Operating activities:Net loss-23,595-17,398-28,309-15,448
Full release

Based on information available as of August 4, 2026, we are reiterating guidance for the full year ending December 31, 2026. These expectations are forward-looking statements and we assume no obligation to update these statements. Actual results may be materially different and are affected by the risk factors and uncertainties identified in this press release and in eHealth’s annual and quarterly reports filed with the Securities and Exchange Commission.

The following guidance is for the full year ending December 31, 2026:

• Total revenue is expected to be in the range of $405.0 million to $445.0 million.

• GAAP net income is expected to be in the range of $8.0 million to $25.0 million.

• Adjusted EBITDA

(1) is expected to be in the range of $55.0 million to $75.0 million.

• Operating cash flow is expected to be in the range of $(10.0) million to $12.0 million.

The above guidance includes the expected impact of positive net adjustment revenue which has been updated to be in the range of $16 million to $20 million to reflect the Q2 2026 positive net adjustment revenue, compared to the previous range of $8 to $20 million.

__________

Note: See accompanying footnotes on page¹⁴.

Webcast and Conference Call Information

A webcast and conference call will be held today, Tuesday, August 4, 2026 at 5:00 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing (833) 461-5787. The participant passcode is 539804356. The live and archived webcast of the call will also be available under “Events & Presentations” on the Investor Relations page of our website at https://ir.ehealthinsurance.com.

About eHealth, Inc.

For nearly 30 years, eHealth, Inc. has helped millions of Americans find the healthcare coverage that fits their needs at a price they can afford, using data, artificial intelligence and a consumer-first approach to help people quickly and effectively compare insurance options. As a leading independent licensed insurance agency and advisor, eHealth offers access to plans from more than 180 health insurers, including national and regional companies, supporting consumers during their working years and retirement. eHealth’s team of licensed insurance agents help match consumers with the insurance plans, services, and support they need to live healthier, more financially secure lives. For more, visit eHealth.com or follow us on

LinkedIn,

Facebook,

Instagram, and

X.

Forward-Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or our future financial or operating performance. These include statements regarding our expectations regarding our business, financial condition, operations and strategy; our strategic objectives in 2026 and beyond, including our lifetime advisory model, business and growth strategy, Individual Coverage Health Reimbursement Arrangements (ICHRA) growth plan, and cost management and cash flow generation efforts, and our ability to achieve such strategic objectives; our estimates regarding approved members and estimated memberships, in the aggregate and by product category; our estimates regarding constrained lifetime values of commissions per approved member by product category; our estimates regarding commissions receivable collection; our estimates regarding costs per approved member; our expectations regarding our profitability and our strategic plans and initiatives, including our lifetime advisory model, product diversification efforts, cost management and cash flow generation, and our ability to execute our operational and strategic plans and initiatives; our 2026 annual guidance for total revenue, GAAP net income, adjusted EBITDA and operating cash flow, and our ability to achieve our financial targets; our estimates for positive net adjustment revenue and its expected impact on our 2026 annual guidance; our expectations regarding our industry and market trends, including market opportunity, consumer demand and our competitive advantage; and other statements regarding our future operations, financial condition, prospects and business strategies.²

These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made. In particular, we are required by Accounting Standards Codification 606 — Revenue from Contracts with Customers to make numerous assumptions that are based on historical trends and our management’s judgment. These assumptions may change over time and have a material impact on our revenue recognition, guidance, and results of operations. Please review the assumptions stated in this press release carefully.

The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, our ability to retain existing members and enroll new members during the annual healthcare open enrollment period, the Medicare annual enrollment period, the Medicare Advantage open enrollment period and other special enrollment periods; changes in laws, regulations and guidelines, including in connection with healthcare reform or with respect to the marketing and sale of Medicare plans; competition, including competition from government-run health insurance exchanges and marketplaces, and other sources; the seasonality of our business and the fluctuation of our operating results; our ability to accurately estimate membership, lifetime value of commissions and commissions receivable; changes in product offerings among carriers on our ecommerce platform and changes in our estimated conversion rate of an approved member to a paying member and the resulting impact of each on our commission revenue; the concentration of our revenue with a small number of health insurance carriers; our ability to execute on our growth strategy and other business initiatives; changes in our senior management or other key employees; our ability to recruit, train, retain and ensure the productivity of licensed insurance agents, or benefit advisors, and other personnel; exposure to security risks and our ability to safeguard the security and privacy of confidential data; our relationships with health insurance carriers; the success of our carrier advertising and sponsorship program; our success in marketing and selling health insurance plans and our unit cost of acquisition; our ability to effectively manage our operations as our business evolves and execute on our business plan and other strategic initiatives; the need for health insurance carrier and regulatory approvals in connection with the marketing of Medicare-related insurance products; changes in the market for private health insurance; consumer satisfaction of our service and actions we take to improve the quality of enrollments; changes in member conversion rates; changes in commission rates; our ability to sell qualified health insurance plans to subsidy-eligible individuals and to enroll subsidy-eligible individuals through government-run health insurance exchanges and marketplaces; our ability to derive desired benefits from investments in our business, including membership growth and retention initiatives; our reliance on marketing partners; the success and cost of our marketing efforts, including branding, online advertising, direct-to-consumer mail, email, social media, telephone, SMS text, television, radio and other marketing efforts; our ability to contact our consumers or market our products through specific channels; timing of receipt and accuracy of commission reports; payment practices of health insurance carriers; risks associated with our operations in China; the restrictions in our debt obligations; the restrictions in our investment agreement with our convertible preferred stock investor; our ability to raise additional capital, including debt or equity financings, on terms acceptable to us or at all; compliance with insurance, privacy, cybersecurity and other laws and regulations; the outcome of litigation, government enforcement actions or regulatory inquiries in which we are or may from time to time be involved, including the complaint filed against us and certain defendants by the U.S. Attorney’s Office for the District of Massachusetts on May 1, 2025 alleging the violation of the Federal False Claims Act; the performance, reliability and availability of our information technology systems and our ability to maintain and improve such systems, ecommerce platform and underlying network infrastructure, including any new systems we may implement; our ability to deploy new and evolving technologies, such as artificial intelligence; public health crises, pandemics, natural disasters and other extreme events; general economic and macroeconomic conditions, including the risks of potential delays, reductions or disruptions in payments from a prolonged government shutdown, inflation, recession, political events, instability or geopolitical tensions, tariffs and trade tensions or other international disputes, financial, banking and credit market disruptions; our ability to effectively administer our self-insurance program; and other risks and uncertainties related to our business. Other factors that could cause our operating, financial and other results to differ are described in our most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission and available on the Investor Relations page of our website at... (truncated)nce.com and on the Securities and Exchange Commission’s website at www.sec.gov.

We have based these forward-looking statements on our current expectations about future events, and these statements are not guarantees of future performance. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Investor Relations Contact

Kate Sidorovich, CFA

Senior Vice President, Investor Relations & Corporate Development investors@ehealth.com https://ir.ehealthinsurance.com³

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.